DSpace at RU >

Search Results

Results 1-21 of 21.

Item hits:

Full Text	Issue Date	Title	Author(s)
	2011	The frequency of the PRKCSH GAG trinucleotide repeat in PCLD patients.	Waanders, E.; Janssen, M.J.; Drenth, J.P.H.
	2011	TET2 mutations in childhood leukemia	Langemeijer, S.M.C.; Jansen, J.H.; Hooijer, J.; Hoogen, P.C.M. van; Stevens-Linders, E.H.P.; Massop, M.; Waanders, E.; Reijmersdal, S.V. van; Stevens-Kroef, M.J.P.L.; Zwaan, C.M.; Heuvel-Eibrink, M.M. van den; Sonneveld, E.; Hoogerbrugge, P.M.; Geurts van Kessel, A.H.M.; Kuiper, R.P.
	2011	Microarray-based genomic profiling as a diagnostic tool in acute lymphoblastic leukemia	Simons, A.; Stevens-Kroef, M.J.P.L.; El Idrissi-Zaynoun, N.; Gessel, S. van; Weghuis, D.O.; Berg, E. van den; Waanders, E.; Hoogerbrugge, P.M.; Kuiper, R.P.; Geurts van Kessel, A.H.M.
	2011	Late recurrence of childhood T-cell acute lymphoblastic leukemia frequently represents a second leukemia rather than a relapse: first evidence for genetic predisposition	Szczepanski, T.; Velden, V.H. van der; Waanders, E.; Kuiper, R.P.; Vlierberghe, P. Van; Gruhn, B.; Eckert, C.; Panzer-Grumayer, R.; Basso, G.; Cave, H.; Stadt, U.Z.; Campana, D.; Schrauder, A.; Sutton, R.; Wering, E. van; Meijerink, J.P.P.; Dongen, J.J. van
	2011	Integrated use of minimal residual disease classification and IKZF1 alteration status accurately predicts 79% of relapses in pediatric acute lymphoblastic leukemia	Waanders, E.; Velden, V.H. van der; Schoot, C.E. van der; Leeuwen, F.N. van; Reijmersdal, S.V. van; Haas, V. de; Veerman, A.J.P.; Geurts van Kessel, A.H.M.; Hoogerbrugge, P.M.; Kuiper, R.P.; Dongen, J.J. van
	2011	Secondary, somatic mutations might promote cyst formation in patients with autosomal dominant polycystic liver disease	Janssen, M.J.; Waanders, E.; Morsche, R.H.M. te; Xing, R.; Dijkman, H.B.P.M.; Woudenberg, J.; Drenth, J.P.H.
	2010	Comment on: How do we interpret an elevated carbohydrate antigen 19-9 level in asymptomatic subjects?	Waanders, E.; Keimpema, L. van; Drenth, J.P.H.
	2010	Secondary and tertiary structure modeling reveals effects of novel mutations in polycystic liver disease genes PRKCSH and SEC63.	Waanders, E.; Venselaar, H.; Morsche, R.H.M. te; Koning, D.B. de; Kamath, P.S.; Torres, V.E.; Somlo, S.; Drenth, J.P.H.
	2010	BTG1 regulates glucocorticoid receptor autoinduction in acute lymphoblastic leukemia.	Galen, J.C. van; Kuiper, R.P.; Emst, J.E. van; Levers, M.R.; Tijchon, E.J.H.; Scheijen, B.; Waanders, E.; Reijmersdal, S.V. van; Gilissen, C.F.H.A.; Geurts van Kessel, A.H.M.; Hoogerbrugge, P.M.; Leeuwen, F.N. van
	2010	Congenital disorders of glycosylation in hepatology: the example of polycystic liver disease.	Janssen, M.J.; Waanders, E.; Woudenberg, J.; Lefeber, D.J.; Drenth, J.P.H.
	2010	IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL.	Kuiper, R.P.; Waanders, E.; Velden, V.H. van der; Reijmersdal, S.V. van; Venkatachalam, R.; Scheijen, B.; Sonneveld, E.; Dongen, J.J.A.M. van; Veerman, A.J.P.; Leeuwen, F.N. van; Geurts van Kessel, A.H.M.; Hoogerbrugge, P.M.
	2009	Carbohydrate antigen 19-9 is extremely elevated in polycystic liver disease.	Waanders, E.; Keimpema, L. van; Brouwer, J.T.; Oijen, M.G.H. van; Aerts, R.; Sweep, C.G.J.; Nevens, F.; Drenth, J.P.H.
	2008	Insights in the molecular pathogenesis of polycystic liver disease : A view from different perspectives.	Waanders, E.
	2008	Hepatocystin is not secreted in cyst fluid of hepalocyst mutant polycystic liver patients	Waanders, E.; Lamers, A.L.L.; Camp, H.J.M. op den; Pluk, W.; Gloerich, J.; Strijk, S.P.; Drenth, J.P.H.
	2008	Value of molecular analysis of Wilson's disease in the absence of tissue copper deposits: a novel ATP7B mutation in an adult patient.	Kok, K.F.; Hoevenaars, B.; Waanders, E.; Drenth, J.P.H.
	2008	Insights in the molecular pathogenesis of polycystic liver disease : a view from different perspectives	Waanders, E.
	2008	Hepatocystin is not secreted in cyst fluid of hepatocystin mutant polycystic liver patients.	Waanders, E.; Lameris, A.L.; Camp, H.J.M. op den; Pluk, W.; Gloerich, J.; Strijk, S.P.; Drenth, J.P.H.
	2008	Cysts of PRKCSH mutated polycystic liver disease patients lack hepatocystin but express Sec63p.	Waanders, E.; Croes, H.J.E.; Maass, C.N.; Morsche, R.H.M. te; Geffen, H.J.J.A.; Krieken, J.H.J.M. van; Fransen, J.A.M.; Drenth, J.P.H.
	2008	Disrupted cell adhesion but not proliferation mediates cyst formation in polycystic liver disease.	Waanders, E.; Krieken, J.H.J.M. van; Lameris, A.L.; Drenth, J.P.H.
	2006	Extensive mutational analysis of PRKCSH and SEC63 broadens the spectrum of polycystic liver disease.	Waanders, E.; Morsche, R.H.M. te; Man, R.A. de; Jansen, J.B.M.J.; Drenth, J.P.H.
	2004	Mammaglobin is associated with low-grade, steroid receptor-positive breast tumors from postmenopausal patients, and has independent prognostic value for relapse-free survival time.	Span, P.N.; Waanders, E.; Manders, P.; Heuvel, J.J.T.M.; Foekens, J.A.; Watson, M.A.; Beex, L.V.A.M.; Sweep, C.G.J.

1